StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a research note issued to investors on Saturday. The firm issued a sell rating on the stock.
Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.
Check Out Our Latest Stock Report on STRM
Streamline Health Solutions Stock Performance
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last issued its earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The business had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.
Streamline Health Solutions Company Profile
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Read More
- Five stocks we like better than Streamline Health Solutions
- Ride Out The Recession With These Dividend Kings
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- ETF Screener: Uses and Step-by-Step Guide
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Investing In Automotive Stocks
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.